{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T05:44:24Z","timestamp":1794635064209,"version":"4.9.1"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Forensic Science International"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.forsciint.2020.110410","type":"journal-article","created":{"date-parts":[[2020,7,10]],"date-time":"2020-07-10T11:34:51Z","timestamp":1594380891000},"page":"110410","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"special_numbering":"C","title":["The synthetic cannabinoid 5F-MDMB-PICA: A case series"],"prefix":"10.1016","volume":"314","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6978-9746","authenticated-orcid":false,"given":"J.","family":"Kleis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Germerott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Halter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"H\u00e9roux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Roehrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.S.","family":"Schwarz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Hess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.forsciint.2020.110410_bib0005","series-title":"EU Drug Markets Report: New Report Highlights Wide-ranging Impacts of EU Drug Markets on Health and Security","author":"EMCDDA","year":"2019"},{"issue":"9","key":"10.1016\/j.forsciint.2020.110410_bib0010","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1021\/acschemneuro.6b00137","article-title":"Pharmacology of Valinate and tert-leucinate synthetic cannabinoids 5F-AMBICA, 5F-AMB, 5F-ADB, AMB-FUBINACA, MDMB-FUBINACA, MDMB-CHMICA, and their analogues","volume":"7","author":"Banister","year":"2016","journal-title":"ACS Chem. Neurosci."},{"issue":"1","key":"10.1016\/j.forsciint.2020.110410_bib0015","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/dta.2201","article-title":"Detection of the recently emerged synthetic cannabinoid 5F-MDMB-PICA in\u2019 legal high\u2019 products and human urine samples","volume":"10","author":"Mogler","year":"2018","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.forsciint.2020.110410_bib0020","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.forsciint.2017.01.023","article-title":"Identification of a new tert-leucinate class synthetic cannabinoid in powder and \"spice-like\" herbal incenses: Methyl 2-1-(5-fluoropentyl)indole-3-carbonylamino-3,3-dimethyl-butanoate (5F-MDMB-PICA)","volume":"273","author":"Risseeuw","year":"2017","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.forsciint.2020.110410_bib0025","article-title":"Critical review report: 5F-MDMB-PICA; Expert committee on drug dependence","author":"World Health Organization","year":"2019","journal-title":"42nd Meeting. Geneva: World Health Organization"},{"key":"10.1016\/j.forsciint.2020.110410_bib0030","series-title":"Schedules of Controlled Substances: Temporary Placement of 5F-EDMB-PINACA, 5F-MDMB-PICA, FUB-AKB48, 5F-CUMYL-PINACA, and FUB-144 Into Schedule I","author":"Drug Enforcement Administration","year":"2019"},{"issue":"3","key":"10.1016\/j.forsciint.2020.110410_bib0035","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1002\/dta.2517","article-title":"Application of an activity-based receptor bioassay to investigate the in vitro activity of selected indole- and indazole-3-carboxamide-based synthetic cannabinoids at CB1 and CB2 receptors","volume":"11","author":"Noble","year":"2019","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.forsciint.2020.110410_bib0040","series-title":"European Drug Report 2018: Trends and Developments","author":"EMCDDA","year":"2018"},{"key":"10.1016\/j.forsciint.2020.110410_bib0045","series-title":"European Drug Report 2019: Trends and Developments","author":"EMCDDA","year":"2019"},{"key":"10.1016\/j.forsciint.2020.110410_bib0050","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1016\/j.forsciint.2019.05.017","article-title":"Mono-\/polyintoxication with 5F-ADB: a case series","volume":"301","author":"Kraemer","year":"2019","journal-title":"Forensic Sci. Int."},{"issue":"7","key":"10.1016\/j.forsciint.2020.110410_bib0055","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1002\/jms.3020","article-title":"Analysis of 30 synthetic cannabinoids in serum by liquid chromatography-electrospray ionization tandem mass spectrometry after liquid-liquid extraction","volume":"47","author":"Kneisel","year":"2012","journal-title":"J. Mass Spectrom."},{"issue":"9","key":"10.1016\/j.forsciint.2020.110410_bib0060","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1002\/dta.2666","article-title":"Detection of the recently emerged synthetic cannabinoid 4F-MDMB-BINACA in \"legal high\" products and human urine specimens","volume":"11","author":"Haschimi","year":"2019","journal-title":"Drug Test. Anal."},{"issue":"5","key":"10.1016\/j.forsciint.2020.110410_bib0065","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1111\/1556-4029.14101","article-title":"4F-MDMB-BINACA: a new synthetic cannabinoid widely implicated in forensic casework","volume":"64","author":"Krotulski","year":"2019","journal-title":"J. Forensic Sci."},{"issue":"162","key":"10.1016\/j.forsciint.2020.110410_bib0070","article-title":"Synthetic and non-synthetic cannabinoid drugs and their adverse Effects-A review from public health prospective","volume":"6","author":"Cohen","year":"2018","journal-title":"Front. Public Health"},{"key":"10.1016\/j.forsciint.2020.110410_bib0075","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.drugalcdep.2014.08.005","article-title":"Synthetic cannabinoids: epidemiology, pharmacodynamics, and clinical implications","volume":"144","author":"Castaneto","year":"2014","journal-title":"Drug Alcohol Depend."},{"issue":"3","key":"10.1016\/j.forsciint.2020.110410_bib0080","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1080\/08897077.2016.1219438","article-title":"Acute effects of synthetic cannabinoids: Update 2015","volume":"38","author":"Tournebize","year":"2017","journal-title":"Subst. Abus."},{"issue":"2","key":"10.1016\/j.forsciint.2020.110410_bib0085","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.pnpbp.2012.04.017","article-title":"Spice drugs are more than harmless herbal blends: a review of the pharmacology and toxicology of synthetic cannabinoids","volume":"39","author":"Seely","year":"2012","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"4","key":"10.1016\/j.forsciint.2020.110410_bib0090","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s00213-013-3188-4","article-title":"Spicing things up: synthetic cannabinoids","volume":"228","author":"Spaderna","year":"2013","journal-title":"Psychopharmacology (Berl.)"},{"issue":"4","key":"10.1016\/j.forsciint.2020.110410_bib0095","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.jadohealth.2011.08.002","article-title":"Synthetic cannabinoid use: a case series of adolescents","volume":"49","author":"Castellanos","year":"2011","journal-title":"J. Adolesc. Health"},{"issue":"4","key":"10.1016\/j.forsciint.2020.110410_bib0100","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1097\/ADM.0b013e31828e1881","article-title":"The synthetic cannabinoid withdrawal syndrome","volume":"7","author":"Nacca","year":"2013","journal-title":"J. Addict. Med."},{"issue":"1","key":"10.1016\/j.forsciint.2020.110410_bib0105","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s00414-013-0864-1","article-title":"Driving under the influence of synthetic cannabinoids (\"Spice\"): a case series","volume":"128","author":"Musshoff","year":"2014","journal-title":"Int. J. Legal Med."},{"issue":"8","key":"10.1016\/j.forsciint.2020.110410_bib0110","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1093\/jat\/bkt065","article-title":"Blood synthetic cannabinoid concentrations in cases of suspected impaired driving","volume":"37","author":"Yeakel","year":"2013","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.forsciint.2020.110410_bib0115","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.aap.2013.09.009","article-title":"Prevalence of synthetic cannabinoids in blood samples from Norwegian drivers suspected of impaired driving during a seven weeks period","volume":"62","author":"Tuv","year":"2014","journal-title":"Accid. Anal. Prev."},{"key":"10.1016\/j.forsciint.2020.110410_bib0120","first-page":"1","article-title":"Characteristics and circumstances of synthetic cannabinoid-related death","author":"Darke","year":"2019","journal-title":"Clin. Toxicol. Phila. (Phila)"},{"issue":"5","key":"10.1016\/j.forsciint.2020.110410_bib0125","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.pcad.2015.11.003","article-title":"Treatment of depression in patients with concomitant cardiac disease","volume":"58","author":"Teply","year":"2016","journal-title":"Prog. Cardiovasc. Dis."},{"key":"10.1016\/j.forsciint.2020.110410_bib0130","series-title":"Disposition of Toxic Drugs and Chemicals in Man","author":"Baselt","year":"2014"},{"issue":"6","key":"10.1016\/j.forsciint.2020.110410_bib0135","doi-asserted-by":"crossref","first-page":"271","DOI":"10.4088\/JCP.v58n0607a","article-title":"Safety in overdose of mirtazapine: a case report","volume":"58","author":"Gerritsen","year":"1997","journal-title":"J. Clin. Psychiatry"},{"issue":"6","key":"10.1016\/j.forsciint.2020.110410_bib0140","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/00004850-199811000-00007","article-title":"Non-fatal mirtazapine overdose","volume":"13","author":"Retz","year":"1998","journal-title":"Int. Clin. Psychopharmacol."},{"issue":"2","key":"10.1016\/j.forsciint.2020.110410_bib0145","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S1570-0232(02)00290-8","article-title":"Determination of mirtazapine and its demethyl metabolite in plasma by high-performance liquid chromatography with ultraviolet detection","volume":"775","author":"Romiguieres","year":"2002","journal-title":"J. Chromatogr. B"},{"issue":"6","key":"10.1016\/j.forsciint.2020.110410_bib0150","first-page":"342","article-title":"Relative safety of mirtazapine overdose","volume":"43","author":"Velazquez","year":"2001","journal-title":"Vet. Hum. Toxicol."},{"key":"10.1016\/j.forsciint.2020.110410_bib0155","series-title":"Mirtazapine-Related Deaths. Washington DC 01.19","author":"Braithwaite RA ESP","year":"2004"},{"key":"10.1016\/j.forsciint.2020.110410_bib0160","first-page":"453","article-title":"Death due to mirtazapine overdose","volume":"47","author":"Nikolaou","year":"2009","journal-title":"Clin. Toxicol."},{"key":"10.1016\/j.forsciint.2020.110410_bib0165","article-title":"Death due to mirtazapine (Remeron) toxicity","author":"Robertson","year":"1999","journal-title":"Puerto Rico"},{"key":"10.1016\/j.forsciint.2020.110410_bib0170","unstructured":"B.R. Hepler, D.S. Isenschmid, CJ. Schmidt. Postmortem redistribution: practical considerations in death investigation. Dallas, Texas 2004 Feb 18."},{"issue":"9","key":"10.1016\/j.forsciint.2020.110410_bib0175","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1093\/jat\/30.9.687","article-title":"Therapeutic and toxic concentrations of mirtazapine","volume":"30","author":"Kirkton","year":"2006","journal-title":"J. Anal. Toxicol."},{"issue":"8","key":"10.1016\/j.forsciint.2020.110410_bib0180","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1002\/cbdv.200790152","article-title":"Human cannabinoid pharmacokinetics","volume":"4","author":"Huestis","year":"2007","journal-title":"Chem. Biodivers."},{"issue":"8","key":"10.1016\/j.forsciint.2020.110410_bib0185","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1093\/jat\/bkt068","article-title":"Toxicological findings of synthetic cannabinoids in recreational users","volume":"37","author":"Kronstrand","year":"2013","journal-title":"J. Anal. Toxicol."},{"issue":"2","key":"10.1016\/j.forsciint.2020.110410_bib0190","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1080\/08897077.2013.846288","article-title":"A survey of synthetic cannabinoid consumption by current cannabis users","volume":"35","author":"Gunderson","year":"2014","journal-title":"Subst. Abus."},{"issue":"12","key":"10.1016\/j.forsciint.2020.110410_bib0195","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1177\/0269881116658990","article-title":"Psychiatric comorbidity associated with synthetic cannabinoid use compared to cannabis","volume":"30","author":"Bassir Nia","year":"2016","journal-title":"J. Psychopharmacol. (Oxford)"},{"issue":"5","key":"10.1016\/j.forsciint.2020.110410_bib0200","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.jemermed.2014.12.038","article-title":"A common source outbreak of severe delirium associated with exposure to the novel synthetic cannabinoid ADB-PINACA","volume":"48","author":"Schwartz","year":"2015","journal-title":"J. Emerg. Med."},{"issue":"1","key":"10.1016\/j.forsciint.2020.110410_bib0205","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/jms.2026","article-title":"Identification of the major urinary metabolites in man of seven synthetic cannabinoids of the aminoalkylindole type present as adulterants in \u2018herbal mixtures\u2019 using LC-MS\/MS techniques","volume":"47","author":"Hutter","year":"2012","journal-title":"J. Mass Spectrom."},{"issue":"7","key":"10.1016\/j.forsciint.2020.110410_bib0210","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1002\/dta.1731","article-title":"Synthetic cannabimimetic agents metabolized by carboxylesterases","volume":"7","author":"Thomsen","year":"2015","journal-title":"Drug Test. Anal."}],"container-title":["Forensic Science International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0379073820302723?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0379073820302723?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T18:02:57Z","timestamp":1759946577000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0379073820302723"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":42,"alternative-id":["S0379073820302723"],"URL":"https:\/\/doi.org\/10.1016\/j.forsciint.2020.110410","relation":{},"ISSN":["0379-0738"],"issn-type":[{"value":"0379-0738","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The synthetic cannabinoid 5F-MDMB-PICA: A case series","name":"articletitle","label":"Article Title"},{"value":"Forensic Science International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.forsciint.2020.110410","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110410"}}